Hung Do Insider Trading $FOLD AMICUS THERAPEUTICS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Hung Do.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Hung Do. Hung Do is Chief Science Officer in AMICUS THERAPEUTICS INC ($FOLD) and Sr Vice President Discovery in AMICUS THERAPEUTICS INC ($FOLD).
Hung Do in AMICUS THERAPEUTICS, INC.
Trading Symbol: FOLDIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Hung Do: Chief Science Officer, Sr Vice President Discovery
Holdings: 448,617 shares
Current Value: $2,700,674
Latest Transaction: Apr 08 2021
$FOLD Market Capitalization: $869.61M
$FOLD Previous Close: $6.02
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Hung Do in AMICUS THERAPEUTICS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 08 2021 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Grant | A | 0.00 | 20,501 | 0 | 448,617 | 428.1 K to 448.6 K (+4.79 %) |
Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 21.84 | 9,960 | 217,477 | 428,116 | 438.1 K to 428.1 K (-2.27 %) |
Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Grant | A | 0.00 | 22,458 | 0 | 438,076 | 415.6 K to 438.1 K (+5.40 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | A | 21.78 | 55,675 | 1,212,602 | 55,675 | |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Grant | A | 0.00 | 34,572 | 0 | 415,618 | 381 K to 415.6 K (+9.07 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 23.09 | 8,938 | 206,378 | 381,046 | 390 K to 381 K (-2.29 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 23.09 | 14,358 | 331,526 | 389,984 | 404.3 K to 390 K (-3.55 %) |
Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 23.09 | 5,340 | 123,301 | 404,342 | 409.7 K to 404.3 K (-1.30 %) |
Dec 16 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 23.88 | 111,125 | 2,653,276 | 409,682 | 520.8 K to 409.7 K (-21.34 %) |
Oct 13 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | M | 9.03 | 75,000 | 677,250 | 0 | |
Oct 13 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | M | 12.28 | 75,000 | 921,000 | 0 | |
Oct 13 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | M | 8.61 | 43,700 | 376,257 | 0 | |
Oct 13 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 15.03 | 193,700 | 2,911,272 | 520,807 | 714.5 K to 520.8 K (-27.11 %) |
Oct 13 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Buy | M | 9.03 | 75,000 | 677,250 | 714,507 | 639.5 K to 714.5 K (+11.73 %) |
Oct 13 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Buy | M | 12.28 | 75,000 | 921,000 | 639,507 | 564.5 K to 639.5 K (+13.29 %) |
Oct 13 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Buy | M | 8.61 | 43,700 | 376,257 | 564,507 | 520.8 K to 564.5 K (+8.39 %) |
Jun 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 11.14 | 1,446 | 16,108 | 520,807 | 522.3 K to 520.8 K (-0.28 %) |
Apr 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Grant | A | 0.00 | 11,354 | 0 | 522,253 | 510.9 K to 522.3 K (+2.22 %) |
Feb 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | M | 5.13 | 17,652 | 90,555 | 19,133 | |
Feb 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | M | 6.10 | 29,148 | 177,803 | 6,270 | |
Feb 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | M | 8.61 | 6,300 | 54,243 | 43,700 | |
Feb 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 11.01 | 63,356 | 697,340 | 510,899 | 574.3 K to 510.9 K (-11.03 %) |
Feb 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Buy | M | 5.13 | 17,652 | 90,555 | 574,255 | 556.6 K to 574.3 K (+3.17 %) |
Feb 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Buy | M | 6.10 | 29,148 | 177,803 | 556,603 | 527.5 K to 556.6 K (+5.53 %) |
Feb 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Buy | M | 8.61 | 6,300 | 54,243 | 527,455 | 521.2 K to 527.5 K (+1.21 %) |
Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 9.46 | 18,904 | 178,832 | 521,155 | 540.1 K to 521.2 K (-3.50 %) |
Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Grant | A | 0.00 | 40,828 | 0 | 540,059 | 499.2 K to 540.1 K (+8.18 %) |
Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 9.46 | 18,904 | 178,832 | 521,155 | 540.1 K to 521.2 K (-3.50 %) |
Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Grant | A | 0.00 | 40,828 | 0 | 540,059 | 499.2 K to 540.1 K (+8.18 %) |
Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 9.18 | 9,330 | 85,649 | 499,231 | 508.6 K to 499.2 K (-1.83 %) |
Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 9.55 | 7,067 | 67,490 | 508,561 | 515.6 K to 508.6 K (-1.37 %) |
Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | A | 9.55 | 107,575 | 1,027,341 | 107,575 | |
Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Grant | A | 0.00 | 68,446 | 0 | 515,628 | 447.2 K to 515.6 K (+15.31 %) |
Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 9.74 | 10,219 | 99,533 | 447,182 | 457.4 K to 447.2 K (-2.23 %) |
Jun 18 2019 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 11.35 | 1,446 | 16,412 | 457,401 | 458.8 K to 457.4 K (-0.32 %) |
Apr 15 2019 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Grant | A | 0.00 | 20,579 | 0 | 458,847 | 438.3 K to 458.8 K (+4.70 %) |
Jan 17 2019 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | M | 5.13 | 30,036 | 154,085 | 36,785 | |
Jan 17 2019 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | M | 2.94 | 4,988 | 14,665 | 0 | |
Jan 17 2019 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | M | 5.13 | 3,800 | 19,494 | 66,821 | |
Jan 17 2019 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | M | 2.94 | 4,400 | 12,936 | 4,988 | |
Jan 17 2019 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 12.05 | 36,669 | 441,861 | 438,268 | 474.9 K to 438.3 K (-7.72 %) |
Jan 17 2019 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Buy | M | 5.13 | 30,036 | 154,085 | 474,937 | 444.9 K to 474.9 K (+6.75 %) |
Jan 17 2019 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Buy | M | 2.94 | 4,988 | 14,665 | 444,901 | 439.9 K to 444.9 K (+1.13 %) |
Jan 17 2019 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 12.00 | 16,600 | 199,200 | 439,913 | 456.5 K to 439.9 K (-3.64 %) |
Jan 17 2019 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Buy | M | 5.13 | 3,800 | 19,494 | 456,513 | 452.7 K to 456.5 K (+0.84 %) |
Jan 17 2019 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Buy | M | 2.94 | 4,400 | 12,936 | 452,713 | 448.3 K to 452.7 K (+0.98 %) |
Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | A | 10.04 | 93,663 | 940,377 | 93,663 | |
Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 10.33 | 9,521 | 98,352 | 448,313 | 457.8 K to 448.3 K (-2.08 %) |
Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Grant | A | 0.00 | 61,063 | 0 | 457,834 | 396.8 K to 457.8 K (+15.39 %) |
Jun 04 2018 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 16.72 | 25,000 | 418,000 | 396,771 | 421.8 K to 396.8 K (-5.93 %) |
May 16 2018 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 15.00 | 25,000 | 375,000 | 421,771 | 446.8 K to 421.8 K (-5.60 %) |
Apr 19 2018 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 15.00 | 50,000 | 750,000 | 446,771 | 496.8 K to 446.8 K (-10.06 %) |
Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | A | 15.67 | 43,075 | 674,985 | 43,075 | |
Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 15.67 | 6,239 | 97,765 | 496,771 | 503 K to 496.8 K (-1.24 %) |
Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Grant | A | 0.00 | 29,803 | 0 | 503,010 | 473.2 K to 503 K (+6.30 %) |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | M | 6.10 | 14,582 | 88,950 | 35,418 | |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | M | 2.94 | 35,612 | 104,699 | 9,388 | |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 14.25 | 50,194 | 715,360 | 473,207 | 523.4 K to 473.2 K (-9.59 %) |
Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Buy | M | 14.25 | 50,194 | 715,360 | 523,401 | 473.2 K to 523.4 K (+10.61 %) |
Jun 19 2017 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Payment of Exercise | F | 8.79 | 1,231 | 10,820 | 473,207 | 474.4 K to 473.2 K (-0.26 %) |
May 23 2017 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 8.00 | 29,914 | 239,312 | 474,438 | 504.4 K to 474.4 K (-5.93 %) |
Feb 09 2017 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 6.00 | 25,000 | 150,000 | 534,266 | 559.3 K to 534.3 K (-4.47 %) |
Jan 17 2017 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 6.00 | 25,000 | 150,000 | 559,266 | 584.3 K to 559.3 K (-4.28 %) |
Jan 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | A | 5.13 | 70,621 | 362,286 | 70,621 | |
Jan 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Grant | A | 0.00 | 50,813 | 0 | 584,266 | 533.5 K to 584.3 K (+9.53 %) |
Nov 03 2016 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 7.00 | 25,000 | 175,000 | 533,453 | 558.5 K to 533.5 K (-4.48 %) |
Oct 04 2016 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 7.25 | 25,000 | 181,250 | 558,453 | 583.5 K to 558.5 K (-4.28 %) |
Sep 08 2016 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 7.00 | 25,000 | 175,000 | 583,453 | 608.5 K to 583.5 K (-4.11 %) |
Aug 08 2016 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 7.00 | 25,000 | 175,000 | 608,453 | 633.5 K to 608.5 K (-3.95 %) |
Jun 17 2016 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | A | 6.10 | 50,000 | 305,000 | 50,000 | |
Jun 17 2016 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Grant | A | 0.00 | 12,500 | 0 | 633,453 | 621 K to 633.5 K (+2.01 %) |
Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | A | 9.03 | 75,000 | 677,250 | 75,000 | |
Sep 16 2015 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 17.75 | 25,000 | 443,668 | 720,953 | 746 K to 721 K (-3.35 %) |
Jun 03 2015 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | A | 12.28 | 75,000 | 921,000 | 75,000 | |
May 29 2015 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | D | 11.77 | 5 | 59 | 745,953 | 746 K to 746 K (0.00 %) |
Apr 28 2015 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Sr Vice President D ... | Sell | D | 11.46 | 41,441 | 474,930 | 745,958 | 787.4 K to 746 K (-5.26 %) |
Mar 27 2015 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Sr Vice President D ... | Sell | D | 10.84 | 41,441 | 449,307 | 787,399 | 828.8 K to 787.4 K (-5.00 %) |
Feb 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Sr Vice President D ... | Sell | D | 8.43 | 41,441 | 349,493 | 828,840 | 870.3 K to 828.8 K (-4.76 %) |
Jan 30 2015 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Sr Vice President D ... | Option Exercise | A | 8.61 | 50,000 | 430,500 | 50,000 | |
Jan 26 2015 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Sr Vice President D ... | Sell | D | 8.10 | 41,441 | 335,548 | 870,281 | 911.7 K to 870.3 K (-4.55 %) |
Dec 24 2014 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Sr Vice President D ... | Sell | D | 8.43 | 41,441 | 349,348 | 911,722 | 953.2 K to 911.7 K (-4.35 %) |
Dec 22 2014 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Sr Vice President D ... | Sell | D | 7.88 | 41,441 | 326,555 | 953,163 | 994.6 K to 953.2 K (-4.17 %) |
Jun 30 2014 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Sr Vice President D ... | Option Exercise | A | 2.94 | 45,000 | 132,300 | 45,000 | |
Mar 14 2014 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Sr Vice President D ... | Sell | D | 2.26 | 22,065 | 49,867 | 994,604 | 1 M to 994.6 K (-2.17 %) |
Mar 14 2014 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Sr Vice President D ... | Sell | D | 2.21 | 85,032 | 187,921 | 1,016,669 | 1.1 M to 1 M (-7.72 %) |
Mar 11 2014 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Sr Vice President D ... | Sell | D | 2.22 | 121,642 | 270,045 | 1,101,701 | 1.2 M to 1.1 M (-9.94 %) |
Mar 11 2014 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Sr Vice President D ... | Sell | D | 2.28 | 108,018 | 246,281 | 1,223,343 | 1.3 M to 1.2 M (-8.11 %) |
Mar 11 2014 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Sr Vice President D ... | Sell | D | 2.32 | 68,418 | 158,730 | 1,331,361 | 1.4 M to 1.3 M (-4.89 %) |
Page: 1